| (BRL) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.29B | — |
| Operating expense | — | — |
| Net income | 1.30B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, REGN34.SA returned +37.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +0.6% |
| 1 year | +37.5% |
| 5 years | +23.7% |
| All-time high | R$111.72 (Aug 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what R$1,000 in REGN34.SA would be worth today ›Yes. Regeneron Pharmaceuticals, Inc. paid 4 dividends over the past 12 months. The most recent was R$0.06 per share on Aug 17, 2026. The dividend yield is 0.31%.
Regeneron Pharmaceuticals, Inc. is part of the Healthcare sector.
Regeneron Pharmaceuticals, Inc. has a market cap of 441.06B BRL, based on the latest quote.
